Drugs & medicalClass II

The Harvard Drug Group LLC dba Major Pharmaceuticals and… recalls Lorazepam Tablets, USP, 0.5mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The…

Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.

Read the official notice →
Date
2025-02-26
Country
United States
Brand
Harvard Drug Group LLC dba Major Pharmaceuticals and…
Product
Lorazepam Tablets, USP, 0.5mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product contained in this…
Classification
Class II
Units
Nationwide U.S. and Puerto rico
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Harvard Drug Group LLC dba Major Pharmaceuticals and… recalls

  1. 2025-08-27
  2. US
    Drugs & medicalClass II

    The Harvard Drug Group LLC dba Major Pharmaceuticals and… recalls Carvedilol Tablets USP, 12.5 mg, 100- Tablets, (10x10) cartons, Rx Only, Packaged and distributed by…

    CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm

    FDA · DrugThe Harvard Drug Group LLC dba Major Pharmaceuticals and…Product was distributed nationwide within the United States.Official notice →
  3. 2025-04-23
  4. US
    Drugs & medicalClass II

    The Harvard Drug Group LLC dba Major Pharmaceuticals and… recalls ChlorproMAZINE Hydrochloride Tablets, USP, 10 mg, packaged in cartons of 100 TABLETS (10x10), Rx only,…

    CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit

    FDA · DrugThe Harvard Drug Group LLC dba Major Pharmaceuticals and…Nationwide USAOfficial notice →
  5. 2025-04-09
  6. US
    Drugs & medicalClass III

    The Harvard Drug Group LLC dba Major Pharmaceuticals and… recalls Tolterodine Tartrate Extended-Release Capsules, 2 mg, 30 Capsules (3 x 10) Unit Dose carton, Rx only,…

    Failed Dissolution Specifications: Out of specification results obtained during routine stability testing for dissolution.

    FDA · DrugThe Harvard Drug Group LLC dba Major Pharmaceuticals and…Nationwide in the USAOfficial notice →
  7. 2025-02-12
  8. US
    Drugs & medicalClass II

    The Harvard Drug Group LLC dba Major Pharmaceuticals and… recalls Potassium Chloride Extended-Release Tablets, USP, 10 mEq (750 mg), 100 Tablets per carton (10 x 10…

    Failed Dissolution Specifications.

    FDA · DrugThe Harvard Drug Group LLC dba Major Pharmaceuticals and…Nationwide in the USAOfficial notice →
  9. 2025-02-05
  10. US
    Drugs & medicalClass II

    The Harvard Drug Group LLC dba Major Pharmaceuticals and… recalls Duloxetine Delayed-Release Capsules USP, 20 mg, packaged in a) 30 Unit Doses (3x10 blister packs) NDC…

    CGMP Deviations: presence of Nitrosamine Drug Substances Related Impurity (NDSRI), N-Nitroso-Duloxetine above the FDA recommended acceptable intake limit

    FDA · DrugThe Harvard Drug Group LLC dba Major Pharmaceuticals and…Nationwide within the United StatesOfficial notice →
  11. 2024-11-27
  12. US
    Drugs & medicalClass II

    The Harvard Drug Group LLC dba Major Pharmaceuticals and… recalls Guaifenesin Dextromethorphan Syrup, 100 mg/10mg per 5 mL, Major Pharmaceuticals 8401 Bearing Drive,…

    Failed Impurity/Degradation Specifications

    FDA · DrugThe Harvard Drug Group LLC dba Major Pharmaceuticals and…Nationwide within the United StatesOfficial notice →
All 15 Harvard Drug Group LLC dba Major Pharmaceuticals and… recalls →

Other drugs & medical recalls in the United States

  1. 2025-02-26
  2. US
    Drugs & medicalClass II

    Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine Capsules, USP, 80 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA,…

    CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.

    FDA · DrugGlenmark Pharmaceuticals Inc., USANationwide within the U.SOfficial notice →
  3. US
  4. US
    Drugs & medicalClass II

    AvKARE recalls Silodosin Capsules, 8mg, 90-count bottle, Rx only, Manufactured for: AvKare, Pulaski, TN 38478, Manufactured by: Amneal Pharmaceuticals of…

    Subpotent Drug: Out of Specification (OOS) result for De hydro Impurity (0.654%) for 18 M Stability sample and low assay 94.9% (specification of NLT 95.0% NMT 105%)

    FDA · DrugAvKAREUSA NationwideOfficial notice →
  5. US
  6. 2025-02-19
  7. US
    Drugs & medicalClass II

    Hologic, Inc recalls Brand Name: Sertera Biopsy Device Product Name: Sertera Biopsy Device Model/Catalog Number: Sertera-14 Software Version: N/A Product…

    Devices presented a condition in which the inner needle separated from the hub and produced a longer throw of the inner needle or dislodgement.

    FDA · DeviceHologic, IncDomestic: Nationwide DistributionOfficial notice →
  8. US
    Drugs & medicalClass II

    Murata Vios, Inc. recalls Vios Monitoring System Bedside Monitor, Model BSM2050, Software Version Numbers 1.54.20 and 1.56.00

    A premature failure condition was identified with the L2050R pulse oximeter SpO2 sensor that connects to the L2050G Vios chest sensor device. When a failure occurs, a Pulse Ox Sensor Off warning condition will be…

    FDA · DeviceMurata Vios, Inc.US Nationwide distribution in the state of NY.Official notice →
See all drugs & medical recalls →